153 related articles for article (PubMed ID: 23359517)
1. The osteopontin-c splice junction is important for anchorage-independent growth.
Shen H; Weber GF
Mol Carcinog; 2014 Jun; 53(6):480-7. PubMed ID: 23359517
[TBL] [Abstract][Full Text] [Related]
2. An osteopontin splice variant induces anchorage independence in human breast cancer cells.
He B; Mirza M; Weber GF
Oncogene; 2006 Apr; 25(15):2192-202. PubMed ID: 16288209
[TBL] [Abstract][Full Text] [Related]
3. Interferon-induced transmembrane 3 binds osteopontin in vitro: expressed in vivo IFITM3 reduced OPN expression.
El-Tanani MK; Jin D; Campbell FC; Johnston PG
Oncogene; 2010 Feb; 29(5):752-62. PubMed ID: 19901966
[TBL] [Abstract][Full Text] [Related]
4. Distinctive Prognostic Value and Cellular Functions of Osteopontin Splice Variants in Human Gastric Cancer.
Hao C; Cui Y; Lane J; Jia S; Ji J; Jiang WG
Cells; 2021 Jul; 10(7):. PubMed ID: 34359989
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis and immunodetection of the bovine milk osteopontin isoforms.
Bissonnette N; Dudemaine PL; Thibault C; Robitaille G
J Dairy Sci; 2012 Feb; 95(2):567-79. PubMed ID: 22281321
[TBL] [Abstract][Full Text] [Related]
7. Expression and characterization of recombinant osteopontin peptides representing matrix metalloproteinase proteolytic fragments.
Gao YA; Agnihotri R; Vary CP; Liaw L
Matrix Biol; 2004 Nov; 23(7):457-66. PubMed ID: 15579312
[TBL] [Abstract][Full Text] [Related]
8. Identification and quantification of osteopontin splice variants in the plasma of lung cancer patients using immunoaffinity capture and targeted mass spectrometry.
Wu J; Pungaliya P; Kraynov E; Bates B
Biomarkers; 2012 Mar; 17(2):125-33. PubMed ID: 22188260
[TBL] [Abstract][Full Text] [Related]
9. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin gene expression determines spontaneous metastatic performance of orthotopic human breast cancer xenografts.
Suzuki M; Mose E; Galloy C; Tarin D
Am J Pathol; 2007 Aug; 171(2):682-92. PubMed ID: 17620367
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer.
Shojaei F; Scott N; Kang X; Lappin PB; Fitzgerald AA; Karlicek S; Simmons BH; Wu A; Lee JH; Bergqvist S; Kraynov E
J Exp Clin Cancer Res; 2012 Mar; 31(1):26. PubMed ID: 22444159
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Osteopontin Splice Variant-c Expression in Breast Cancers: A Meta-Analysis.
Hao C; Wang Z; Gu Y; Jiang WG; Cheng S
Biomed Res Int; 2016; 2016():7310694. PubMed ID: 27462610
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin-c splicing isoform contributes to ovarian cancer progression.
Tilli TM; Franco VF; Robbs BK; Wanderley JL; da Silva FR; de Mello KD; Viola JP; Weber GF; Gimba ER
Mol Cancer Res; 2011 Mar; 9(3):280-93. PubMed ID: 21263033
[TBL] [Abstract][Full Text] [Related]
14. Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer.
Allan AL; George R; Vantyghem SA; Lee MW; Hodgson NC; Engel CJ; Holliday RL; Girvan DP; Scott LA; Postenka CO; Al-Katib W; Stitt LW; Uede T; Chambers AF; Tuck AB
Am J Pathol; 2006 Jul; 169(1):233-46. PubMed ID: 16816376
[TBL] [Abstract][Full Text] [Related]
15. Silencing of osteopontin promotes the radiosensitivity of breast cancer cells by reducing the expression of hypoxia inducible factor 1 and vascular endothelial growth factor.
Yang L; Zhao W; Zuo WS; Wei L; Song XR; Wang XW; Zheng G; Zheng MZ
Chin Med J (Engl); 2012 Jan; 125(2):293-9. PubMed ID: 22340562
[TBL] [Abstract][Full Text] [Related]
16. EF1A1-actin interactions alter mRNA stability to determine differential osteopontin expression in HepG2 and Hep3B cells.
Zhang J; Guo H; Mi Z; Gao C; Bhattacharya S; Li J; Kuo PC
Exp Cell Res; 2009 Jan; 315(2):304-12. PubMed ID: 19026636
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of osteopontin expression by RNA interference affects cell proliferation and chemotherapy sensitivity of breast cancer MDA-MB-231 cells.
Yang L; Wei L; Zhao W; Wang X; Zheng G; Zheng M; Song X; Zuo W
Mol Med Rep; 2012 Feb; 5(2):373-6. PubMed ID: 22143930
[TBL] [Abstract][Full Text] [Related]
18. Influence of osteopontin expression on the metastatic growth of CC531 rat colorectal carcinoma cells in rat liver.
Uhlmann ME; Georges RB; Boleij A; Eyol E; Kubarenko A; Adwan H; Berger MR
Cancer Gene Ther; 2011 Nov; 18(11):795-805. PubMed ID: 21852811
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 suppresses osteopontin-mediated breast cancer.
El-Tanani MK; Campbell FC; Crowe P; Erwin P; Harkin DP; Pharoah P; Ponder B; Rudland PS
J Biol Chem; 2006 Sep; 281(36):26587-601. PubMed ID: 16807234
[TBL] [Abstract][Full Text] [Related]
20. RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin.
Kurisetty VV; Johnston PG; Johnston N; Erwin P; Crowe P; Fernig DG; Campbell FC; Anderson IP; Rudland PS; El-Tanani MK
Oncogene; 2008 Dec; 27(57):7139-49. PubMed ID: 18794800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
